Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Sg Stroes

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Current Opinion in Lipidology|August 9, 2022
Considerations for routinely testing for high lipoprotein(a)Nick S Nurmohamed, Patrick M Moriarty, Erik Sg Stroes
European Journal of Preventive Cardiology|July 29, 2020
Next-generation sequencing to confirm clinical familial hypercholesterolemiaLaurens F Reeskamp, Tycho R Tromp, Joep C Defesche, et al.
Proteome Science|June 30, 2011
High-density lipoprotein proteome dynamics in human endotoxemiaJohannes Hm Levels, Pierre Geurts, Helen Karlsson, et al.
European Journal of Preventive Cardiology|July 31, 2019
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapyChristie M Ballantyne, Ulrich Laufs, Kausik K Ray, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Current Opinion in Lipidology|August 9, 2022
Considerations for routinely testing for high lipoprotein(a)Nick S Nurmohamed, Patrick M Moriarty, Erik Sg Stroes
European Journal of Preventive Cardiology|July 29, 2020
Next-generation sequencing to confirm clinical familial hypercholesterolemiaLaurens F Reeskamp, Tycho R Tromp, Joep C Defesche, et al.
Proteome Science|June 30, 2011
High-density lipoprotein proteome dynamics in human endotoxemiaJohannes Hm Levels, Pierre Geurts, Helen Karlsson, et al.
European Journal of Preventive Cardiology|July 31, 2019
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapyChristie M Ballantyne, Ulrich Laufs, Kausik K Ray, et al.
Pageof 1